title: Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler's diarrhea.
abstract: The non-toxic B subunit (CT-B) of cholera toxin from Vibrio cholerae is a strong immunogen and amplifies the immune reaction to conjugated antigens. In this work, a synthetic gene encoding for CT-B was expressed under control of a γ-zein promoter in maize seeds. Levels of CT-B in maize plants were determined via ganglioside dependent ELISA. The highest expression level recorded in T(1) generation seeds was 0.0014% of total aqueous soluble protein (TASP). Expression level of the same event in the T(2) generation was significantly increased to 0.0197% of TASP. Immunogenicity of maize derived CT-B was evaluated in mice with an oral immunization trial. Anti-CTB IgG and anti-CTB IgA were detected in the sera and fecal samples of the orally immunized mice, respectively. The mice were protected against holotoxin challenge with CT. An additional group of mice was administrated with an equal amount (5 μg per dose each) of mixed maize-derived CT-B and LT-B (B subunit of E. coli heat labile toxin). In the sera and fecal samples obtained from this group, the specific antibody levels were enhanced compared to either the same or a higher amount of CT-B alone. These results suggest that a synergistic action may be achieved using a CT-B and LT-B mixture that can lead to a more efficacious combined vaccine to target diarrhea induced by both cholera and enterotoxigenic strains of Escherichia coli.
authors.affiliation: Interdepartmental Plant Biology Major, Iowa State University, Ames, IA 50011, USA.
authors.forename: S
authors.initials: S
authors.lastname: Karaman
authors.forename: J
authors.initials: J
authors.lastname: Cunnick
authors.forename: K
authors.initials: K
authors.lastname: Wang
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood*; D001427:Bacterial Toxins / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D002771:Cholera / Q000517:prevention & control*; D002772:Cholera Toxin / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics; D003967:Diarrhea / Q000517:prevention & control*; D004357:Drug Synergism; D004768:Enterotoxins / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics; D004926:Escherichia coli / Q000276:immunology; D029968:Escherichia coli Proteins / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics; D005243:Feces; D005260:Female; D018928:Immunity, Mucosal; D007114:Immunization; D051379:Mice; D008807:Mice, Inbred BALB C; D030821:Plants, Genetically Modified; D011401:Promoter Regions, Genetic / Q000235:genetics; D012639:Seeds / Q000235:genetics / Q000378:metabolism; D019076:Transgenes; D014734:Vibrio cholerae / Q000276:immunology; D003313:Zea mays / Q000235:genetics / Q000378:metabolism*
chemical_list: D000907:Antibodies, Bacterial; D001427:Bacterial Toxins; D001428:Bacterial Vaccines; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D002772:Cholera Toxin; C027538:heat-labile enterotoxin, E coli